European Commission. (2017) Evaluation of the implementation of the EU drugs strategy 2013-2020 and of the EU action plan on drugs 2013-2016: a continuous need for an EU action plan on drugs 2017-2020. Brussels: European Commission.
Preview | Title | Contact |
---|---|---|
|
PDF (Evaluation of the implementation of the EU drugs strategy 2013-2020)
- Published Version
605kB |
The EU's Drugs Strategy 2013-2020 and its first Action Plan on Drugs 2013-2016 set out a political framework and priorities for the EU’s drugs policy. The Strategy provides a single, evidence-based framework for tackling drugs inside and outside the EU, and is based on a five pillar structure consisting of:
two main policy areas
the reduction of the drug demand and
the reduction of drug supply;
and three cross-cutting themes:
coordination,
international cooperation and
research, information, monitoring and evaluation.
The Strategy requires the Commission to "initiate an external midterm assessment of the Strategy by 2016, in view of preparing a second Action Plan for the period 2017-2020". The European Agenda on Security provides for the Commission to assess progress in implementing the 2013-2016 Action Plan and decide on that basis whether to propose a new Action Plan for 2017-2020.
Repository Staff Only: item control page